Torpedo Therapeutics
YC W22Boston, US · Founded 2018 · 5 employees · 1 known investors
Torpedo Therapeutics develops high-precision, closed-loop deep brain stimulation devices for treating neurological disorders including Parkinson's disease, essential tremor, dystonia, and drug-resistant epilepsy. The company uses micro- and nano-fabrication to create ultra-small electrode leads with machine learning-driven parameter adjustment to reduce side effects and improve treatment efficacy.
Also known as Neural Dynamics · Neural Dynamics Technologies · Neural Dynamics Technologies Inc. · Neural Dynamics Technologies LLC
AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesNeurotechnologyUnited States of AmericaAmerica / Canada
Founders & leadership· Y Combinator alumni (W22)
Torpedo Therapeutics was founded in 2018 by Ingrid van Welie.
IV
Ingrid van Weliein𝕏Founder and CEOIngrid van Welie holds a PhD and founded Torpedo Therapeutics, where she serves as CEO. Her background is in neuroscience and biophysics, with focus on technologies for measuring and modulating neuronal electrical activity.
Investors · 1
Frequently asked questions
- What does Torpedo Therapeutics do?
- Torpedo Therapeutics develops high-precision, closed-loop deep brain stimulation devices for treating neurological disorders including Parkinson's disease, essential tremor, dystonia, and drug-resistant epilepsy. The company uses micro- and nano-fabrication to create ultra-small electrode leads with machine learning-driven parameter adjustment to reduce side effects and improve treatment efficacy.
- Who founded Torpedo Therapeutics?
- Torpedo Therapeutics was founded by Ingrid van Welie in 2018.
- Who are Torpedo Therapeutics's investors?
- Torpedo Therapeutics's investors include Y Combinator.
- Where is Torpedo Therapeutics headquartered?
- Torpedo Therapeutics is headquartered in Boston, US.